It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lipid droplets (LDs) are dynamic organelles that contain an oil core mainly composed of triglycerides (TAG) that is surrounded by a phospholipid monolayer and LD-associated proteins called perilipins (PLINs). During LD biogenesis, perilipin 3 (PLIN3) is recruited to nascent LDs as they emerge from the endoplasmic reticulum. Here, we analyze how lipid composition affects PLIN3 recruitment to membrane bilayers and LDs, and the structural changes that occur upon membrane binding. We find that the TAG precursors phosphatidic acid and diacylglycerol (DAG) recruit PLIN3 to membrane bilayers and define an expanded Perilipin-ADRP-Tip47 (PAT) domain that preferentially binds DAG-enriched membranes. Membrane binding induces a disorder to order transition of alpha helices within the PAT domain and 11-mer repeats, with intramolecular distance measurements consistent with the expanded PAT domain adopting a folded but dynamic structure upon membrane binding. In cells, PLIN3 is recruited to DAG-enriched ER membranes, and this requires both the PAT domain and 11-mer repeats. This provides molecular details of PLIN3 recruitment to nascent LDs and identifies a function of the PAT domain of PLIN3 in DAG binding.
Perilipin 3 binds to emerging lipid droplets from the endoplasmic reticulum. Choi and Ajjaji et al characterize the molecular mechanisms of Perilipin 3 recruitment to membranes and uncover a function for the PAT domain in diacylglycerol sensing.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Stony Brook University, Department of Biochemistry and Cell Biology, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
2 ENS, Université PSL, CNRS, Sorbonne Université, Université Paris Cité, Laboratoire de Physique de l’École normale supérieure, Paris, France (GRID:grid.462608.e) (ISNI:0000 0004 0384 7821)
3 University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465)
4 Cornell University, National Biomedical Resource for Advanced Electron Spin Resonance Technology (ACERT), Ithaca, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Cornell University, Department of Chemistry and Chemical Biology, Ithaca, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
5 Stony Brook University, Department of Chemistry, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
6 University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465); The University of British Columbia, Department of Biochemistry and Molecular Biology, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)